Suscripción a Biblioteca: Guest
Journal of Environmental Pathology, Toxicology and Oncology

Publicado 4 números por año

ISSN Imprimir: 0731-8898

ISSN En Línea: 2162-6537

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.4 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.8 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.5 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00049 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.59 SJR: 0.429 SNIP: 0.507 CiteScore™:: 3.9 H-Index: 49

Indexed in

CD10 and E-Cad Expression in Urinary Bladder Urothelial and Squamous Cell Carcinoma

Volumen 31, Edición 3, 2012, pp. 203-212
DOI: 10.1615/JEnvironPatholToxicolOncol.v31.i3.20
Get accessGet access

SINOPSIS

Identification of prognostic markers in bladder carcinoma comprises a major clinical issue and therapeutic target. CD10 and the adhesion molecule E-cadherin (E-cad) are expressed in a variety of normal tissues and their neoplasms. CD10 is able to degrade extracellular matrix and other proteins, including adhesion molecules. The roles of CD10 and E-cad and their relationship in the development and progression of bladder carcinoma are poorly understood. The aim of this study was to investigate the expression of CD10 and E-cad in bladder carcinomas and relate the results to the established prognostic factors. This study included 144 patients with bladder carcinoma, including 72 with transitional cell carcinoma (TCC; 30 bilharzial and 42 nonbilharzial) and 72 with squamous cell carcinoma (SCC; 38 bilharzial and 34 nonbilharzial). Immunohistochemical analysis for both CD10 and E-cad were carried out on paraffin-fixed sections of neoplastic bladder tissues. CD10 tumor cells, CD10 stromal cells, and E-cad were expressed in 56%, 58%, and 51% of cancer bladder cases, respectively. There was a statistically significant correlation between percentage of tumor cells positively stained by CD10 and each of the tumor grade, clinical stage, and lymph node metastasis of both TCC and SCC. There was a significant statistical correlation between immunostaining by E-cad marker and each of the tumor grade, clinical stage, and lymph node metastasis of TCC, but no such association with SCC. The frequency of stromal expression of CD10 was higher in bilharzial-associated bladder carcinomas than in nonbilharzial ones, and these results were statistically significant. In conclusion, increased expression of CD10 in the tumor and stromal cells of both TCC and SCC and decreased expression of E-cad in the tumor cells of only TCC are strongly correlated with tumor progression, invasion, and metastasis in human bladder cancer.

CITADO POR
  1. Ahmed Ahmed R.H., Muhammad Eman M.S., E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions, Journal of the Egyptian National Cancer Institute, 26, 4, 2014. Crossref

  2. Hussain Maha, Daignault Stephanie, Agarwal Neeraj, Grivas Petros D., Siefker-Radtke Arlene O., Puzanov Igor, MacVicar Gary R., Levine Ellis Glenn, Srinivas Sandy, Twardowski Przemyslaw, Eisenberger Mario A., Quinn David I., Vaishampayan Ulka N., Yu Evan Y., Dawsey Scott, Day Kathleen C., Day Mark L., Al-Hawary Mahmoud, Smith David C., A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma, Cancer, 120, 17, 2014. Crossref

  3. Wong Thian-Sze, Gao Wei, Chan Jimmy Yu-Wai, Transcription Regulation of E-Cadherin by Zinc Finger E-Box Binding Homeobox Proteins in Solid Tumors, BioMed Research International, 2014, 2014. Crossref

  4. Ghafouri-Fard Soudeh, Nekoohesh Leili, Motevaseli Elahe, Bladder Cancer Biomarkers: Review and Update, Asian Pacific Journal of Cancer Prevention, 15, 6, 2014. Crossref

  5. Tian Wei, Epstein Jonathan I., Invasive low-grade papillary urothelial carcinoma: an immunohistochemical study of 26 cases, Human Pathology, 46, 12, 2015. Crossref

  6. Stephen H M, Khoury R J, Majmudar P R, Blaylock T, Hawkins K, Salama M S, Scott M D, Cosminsky B, Utreja N K, Britt J, Conway R E, Epigenetic suppression of neprilysin regulates breast cancer invasion, Oncogenesis, 5, 3, 2016. Crossref

  7. Stivarou Theodora, Patsavoudi Evangelia, Extracellular Molecules Involved in Cancer Cell Invasion, Cancers, 7, 1, 2015. Crossref

  8. Oba Junna, Nakahara Takeshi, Hashimoto-Hachiya Akiko, Liu Min, Abe Takeru, Hagihara Akihito, Yokomizo Takehiko, Furue Masutaka, Dadras Soheil S., CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis, PLOS ONE, 11, 2, 2016. Crossref

  9. Apollo Alessandro, Ortenzi Valerio, Scatena Cristian, Zavaglia Katia, Aretini Paolo, Lessi Francesca, Franceschi Sara, Tomei Sara, Sepich Carlo Alberto, Viacava Paolo, Mazzanti Chiara Maria, Naccarato Antonio Giuseppe, Real Francisco X., Molecular characterization of low grade and high grade bladder cancer, PLOS ONE, 14, 1, 2019. Crossref

  10. Maia Manuel Caitano, Hansen Aaron, Alves Carolina, Salah Samer, Biomarkers in Non-Schistosomiasis-related squamous cell carcinoma of the urinary bladder: A review, Critical Reviews in Oncology/Hematology, 135, 2019. Crossref

  11. Shukla SushilKumar, Chandra Smita, Chauhan Neena, Sarpal Rajeev, Expression of CD10 in urothelial carcinoma of the bladder and its correlation with histopathological grade, pathological stage, and survival of patients, Journal of Cancer Research and Therapeutics, 17, 4, 2021. Crossref

Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain